Compare · EW vs SERV
EW vs SERV
Side-by-side comparison of Edwards Lifesciences Corporation (EW) and Serve Robotics Inc. (SERV): market cap, price performance, sector, and recent activity on the wire.
Summary
- EW operates in Health Care, while SERV operates in Consumer Discretionary - the two are in different parts of the market.
- EW carries a market cap of $49.36B.
- Over the past year, EW is up 11.9% and SERV is down 54.0% - EW leads by 66.0 points.
- EW has hit the wire 6 times in the past 4 weeks while SERV has been quiet.
- EW has more recent analyst coverage (25 ratings vs 8 for SERV).
- Company
- Edwards Lifesciences Corporation
- Serve Robotics Inc.
- Price
- $85.70-2.46%
- $5.09-3.60%
- Market cap
- $49.36B
- -
- 1M return
- -3.25%
- -22.29%
- 1Y return
- +11.92%
- -54.04%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NYSE
- NYSE
- IPO
- News (4w)
- 6
- 0
- Recent ratings
- 25
- 8
Edwards Lifesciences Corporation
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral regurgitation, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products, oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Latest EW
- Edwards Lifesciences to Host Earnings Conference Call on July 23, 2026
- CVP, EMEACLA Bruls Annette covered exercise/tax liability with 109 shares, decreasing direct ownership by 0.53% to 20,628 units (SEC Form 4) (for withholding tax)
- CVP, Chief Financial Officer Mistras Theodora was granted 99,920 shares (SEC Form 4)
- CVP, TAVR Lippis Daniel J. exercised 619 shares at a strike of $72.68 and sold $56,762 worth of shares (619 units at $91.70) as part of a pre-agreed trading plan (SEC Form 4)
- CVP, TAVR Lippis Daniel J. covered exercise/tax liability with 377 shares, decreasing direct ownership by 0.93% to 40,034 units (SEC Form 4) to cover taxes
- CVP, TAVR Lippis Daniel J. exercised 619 shares at a strike of $72.68 and sold $56,577 worth of shares (619 units at $91.40) as part of a pre-agreed trading plan (SEC Form 4)
- Edwards’ Structural Heart Leadership Demonstrated Through Expanding Body of Scientific Evidence at New York Valves
- CEO Zovighian Bernard J sold $45,982 worth of shares (523 units at $87.92) as part of a pre-agreed trading plan (SEC Form 4)
- SEC Form 11-K filed by Edwards Lifesciences Corporation
- SEC Form 11-K filed by Edwards Lifesciences Corporation
Latest SERV
- Director Lieber Andreas was granted 20,000 shares (SEC Form 4)
- SEC Form 3 filed by new insider Lieber Andreas
- Serve Robotics Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- Serve Robotics Appoints Andreas Lieber to Board of Directors
- Local Artists Turn Serve's Delivery Robots into Public Art with the Launch of Moving Canvas
- Director Vincent Olivier was granted 20,000 shares, increasing direct ownership by 67% to 49,928 units (SEC Form 4)
- Director Sarafan Lily was granted 20,000 shares, increasing direct ownership by 34% to 78,402 units (SEC Form 4)
- Director Goldberg David Michael sold $76,320 worth of shares (10,600 units at $7.20) as part of a pre-agreed trading plan and was granted 20,000 shares, increasing direct ownership by 21% to 55,125 units (SEC Form 4)
- Serve Robotics Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- SEC Form SCHEDULE 13G filed by Serve Robotics Inc.